However, the relationship between lactate levels and the well-validated Sequential Organ Failure Assessment (SOFA) score (7) (8) (9) (10) (11) has not yet been studied. Although lactate as a biomarker and SOFA as an organ dysfunction scale have different functions, an association between the two might have clinical implications. Blood lactate measurement may act as a real-time marker for the severity of organ failure, whereas calculating the SOFA score takes 24 hrs. This might improve therapy by adapting resuscitation to serial lactate measurements, which might prevent organ failure and eventually improve clinical outcome.
Because the SOFA score comprises scores from six different organ systems, it is also possible to evaluate the association of lactate with separate organ systems. It is unknown to which extent the cardiovascular and other SOFA subscores are related to lactate levels.
The aim of our study was to evaluate whether the level and duration of in-creased blood lactate levels (represented by the area under the lactate curve) are associated with daily SOFA scores and the separate organ subscores and to evaluate whether these associations are time-dependent (early vs. late phase of intensive care unit [ICU stay]). We hypothesize that increased lactate levels will be associated with higher SOFA scores and that this association will be stronger in the early phase than in the late phase.
PATIENTS AND METHODS
Design. This was a retrospective observational study in the mixed ICU of a tertiary care university hospital.
Patients. Consecutive ICU patients with available lactate measurements who were admitted in January and February 2005 were eligible for study participation. Patients admitted with acute or chronic liver failure, defined as the presence of any kind of liver disease and a prothrombin time Ͼ15 secs, were excluded. The study was exempt from review and approval of the Local Ethics Committee by the Dutch Central Committee on research involving Human Subjects, which waived the need for informed consent.
Data Collection. Data from the first 28 days spent in the ICU were collected retrospectively from the electronic patient data monitoring system and hospital administration database. We collected demographic information, serial blood lactate levels, and relevant variables for calculation of daily SOFA scores. The Glasgow Coma Scale collected in sedated patients was the assumed score without sedation. Mortality and length of stay were recorded; 28-day mortality was the primary outcome measure to evaluate survival.
SOFA Scores. SOFA scores were calculated every day that a patient was staying in the ICU during the observation period of maximal 28 days. To calculate the SOFA score, the worst value for each variable in each 24-hr period was used. If variables that were required to calculate the SOFA score were missing, they were regarded as normal until the first real variable was available. For any missing value thereafter, the last known real value was used. The following SOFA-derived variables were used (8):
1. Initial SOFA: the SOFA score on the first day of ICU admission (from time of admission to 24 hrs following admission, e.g., from 6 AM to 6 AM the next day).
2. Max SOFA: the highest daily SOFA score during the observation period (maximal 28 days following ICU admission). 3. Total SOFA: the sum of all daily SOFA scores during the observation period. 4. Mean SOFA: the total SOFA score divided by the number of days spent on the ICU during the observation period.
Multiple organ failure was defined as a score of Ն3 on two or more different individual organs of the SOFA score on any day during the observation period (12) .
Lactate. Lactate levels were measured in arterial blood using point-of-care blood gas analyzers (ABL 700, Radiometer Copenhagen, Denmark, upper normal limit 2.0 mmol/L). Lactate buffer solutions for renal replacement therapy and continuous epinephrine infusion were not used during the study period.
The area under the curve of lactate levels (lactate AUCϾ2 ) above the threshold of 2.0 mmol/L was calculated daily using the following formula: Initial (day 1) utes. Subsequently, lactate AUCϾ2 was converted into days⅐mmol/L). Figure 1 clarifies the formula. Lactate AUCϾ2 was zero if lactate levels did not exceed the threshold of 2.0 mmol/L. Lactate AUCϾ2 was expressed as the value on the day of admission (initial lactate AUCϾ2 ), the maximum of daily calculations of lactate AUCϾ2 (maximal lactate AUCϾ2 ), the sum of all daily calculations (total lactate AUCϾ2 ) and the mean of all daily calculations (mean lactate AUCϾ2 ).
Statistics. Values are described as medians with interquartile ranges. Kruskal-Wallis tests were performed to compare survivors and nonsurvivors and those with and without hyperlactatemia. To evaluate the prognostic value of SOFA and lactate AUCϾ2 , univariate Cox proportional hazards models were performed. Daily SOFA scores were related to daily lactate AUCϾ2 using mixed-model analysis of variance. In this way, between-patient and within-patient variations (e.g., within a single patient, the score on day 4 is correlated to the score on day 5, on day 6, and so on) of daily SOFA scores were taken into account. The day-to-day correlation of within-patient SOFA scores was assumed to have a first-order autoregressive structure. The effects of daily values of lactate AUCϾ2 on daily SOFA were also estimated separately during the early and late phase of ICU stay; because consensus time definitions are unavailable, we arbitrarily defined the early phase of ICU stay as before the (A and B) 0, n ϭ 88; 0 -1, n ϭ 22; 1-2, n ϭ 10; 2-3, n ϭ 5; Ͼ3, n ϭ 9. Max lactate AUCϾ2 (C and D) 0, n ϭ 78; 0 -1, n ϭ 22; 1-2, n ϭ 13; 2-3, n ϭ 11; Ͼ3, n ϭ 10. Total lactate AUCϾ2 (E and F) 0, n ϭ 78; 0 -1, n ϭ 21; 1-2, n ϭ 9; 2-3, n ϭ 8; Ͼ3, n ϭ 18. median length of ICU stay 2.75 days). Finally, the daily individual SOFA organ scores were related to daily lactate AUCϾ2 . We considered p Ͻ .05 to be statistically significant. Data were analyzed using the SPSS/PC program (version 10.1.0/12.0.1, SPSS, Chicago, IL).
RESULTS
During the study period 205 patients were admitted to the ICU. Eleven patients were excluded because of liver failure, and lactate was not measured within the first 24 hrs of ICU admission in another 60 patients. The baseline and clinical characteristics of the remaining 134 patients are displayed in Table 1 . In total, 2,627 lactate levels were available, which corresponded to an average of three measurements per patient per day. Median lactate at admission was 1.3 mmol/L (interquartile range 0.8 -2.3), with a range between 0.5 and 19.0 mmol/L. Twentynine percent of the patients had hyperlactatemia (Ͼ2.0 mmol/L) at admission, 34% had hyperlactatemia within the first 24 hrs, and 42% had hyperlactatemia at any time during their ICU stay.
SOFA and Lactate in Survivors and
Nonsurvivors. Generally, SOFA and lactate AUCϾ2 were higher in 28-day nonsurvivors than in survivors (Table 2) . Initial, maximal, and mean (but not total) values of SOFA and lactate AUCϾ2 significantly predicted 28-day mortality ( Table 3) .
Hyperlactatemia and SOFA. Generally, the risk of multiple organ failure or death increased when lactate levels were higher for a longer period (Fig. 2) . In patients with hyperlactatemia (lactate AUCϾ2 Ͼ0, n ϭ 56) compared with normolactatemic patients (lactate AUCϾ2 ϭ 0, n ϭ 78), all SOFA-derived variables were significantly higher (Fig. 3) .
The daily lactate AUCϾ2 was significantly associated with the daily SOFA score. The overall relationship between the two variables was an increase of 0.62 SOFA points per 1 day⅐mmol/L of lactate AUCϾ2 (95% confidence interval, 0.41-0.81, p Ͻ .00001). During the early phase of ICU stay (before a median of 2.75 days), the relationship between lactate AUCϾ2 and SOFA was 1.01 SOFA points per 1 day⅐mmol/L of lactate AUCϾ2 (95% confi-dence interval, 0.53-1.50, p Ͻ .0005). During the later ICU stay (Ͼ2.75 days), this was 0.50 SOFA points per 1 day⅐mmol/L of lactate AUCϾ2 (95% confidence interval, 0.28 -0.72, p Ͻ .0005).
Hyperlactatemia and Individual SOFA Organ Scores. The initial, maximal, total, and mean scores of almost all individual organ systems were higher in patients with hyperlactatemia compared with those without hyperlactatemia (Table 4 ). However, lactate was only significantly associated with respiratory and coagulation systems during overall ICU admission when we specifically looked at the effect of increases in lactate AUCϾ2 on different organs in mixed model analysis ( Table 5 ). In the early phase of ICU admission, increases in lactate levels were also associated with cardiovascular and renal dysfunction, but this association disappeared during the late phase.
DISCUSSION
We found a clear association between lactate and SOFA, which was stronger in the early phase of ICU admission compared with the late phase. This provides additional indirect support for the importance of early resuscitation in the prevention of organ failure (13) (14) (15) (16) (17) . Possibly, serial lactate measurements may guide the process of optimizing oxygen delivery in this early phase (http://www.clinicaltrials.gov/ct/ show/NCT00270673?orderϭ1).
In terms of the individual organ systems, the cardiovascular subscore was not strongly associated with lactate levels ( Table 5 ). This emphasizes the phenomenon of occult hypoperfusion in which hypotension is not a necessary characteristic for the presence of raised blood lactate levels (18 -20) . In addition, many aerobic mechanisms of hyperlactatemia, not related to tissue hypoxia, have been described in critically ill patients (21) . However, despite the weak overall association of the cardiovascular system with lactate, there was a significant and clinically relevant association in the early phase, but this later disappeared (Table  5) . Apparently, the link between the severity of the initial insult, cardiovascular collapse, and an increase in lactate levels is stronger in the early phase.
Respiratory and coagulation subscores were most strongly associated with lactate (Table 5 ). An increased SOFA respiratory subscore often indicates the presence of acute lung injury or ARDS, which directly influences severity of disease and outcome (22) . The lung has been described as an important source of lactate (23) , probably reflecting metabolic adaptations in response to inflammatory mediators rather than actual tissue hypoxia (24) . The SOFA coagulation subscore is a more indirect marker of critical illness: a link exists from thrombocytopenia via disseminated intravascular coagulation to hyperlactatemia and unfavorable outcomes (25) . Similar to the platelet count, lactate might possibly act as a general biomarker of critical illness (21, 26) . Because liver dysfunction can lead to hyperlactatemia (27, 28) , it was remarkable that the liver subscore was not related to lactate. Probably, the number of patients with liver dysfunction was too small for a statistically significant association because we excluded patients with acute or chronic liver failure and because liver failure is less prevalent compared with other organ failure in critically ill patients (1) .
Finally, our data reconfirm the prognostic value of SOFA and lactate for mortality (18, 29, 30) . Only total SOFA and total lactate AUCϾ2 did not predict 28-day mortality ( Table 3) : it is difficult to establish a relationship between total values and survival in patients who died early, because they could not accumulate many SOFA points or a high lactate AUCϾ2 , whereas they were the most severely ill (8) .
Our study has limitations. First, although we focused on individual organs by evaluating SOFA subscores, this observational study does not allow speculation on the cause of the link between hyperlactatemia and organ dysfunction. Second, this was a retrospective observational study, which does not us to draw definitive conclusions; prospective validation of our findings is required. We did not conduct a prospective trial be- Effects of an increase of 1 day⅐mmol/L in daily lactate AUCϾ2 on the daily different SOFA organ subscores. The effects are shown for overall ICU stay and then separated for the early (Ͻ2.75 days) and late (Ͼ2.75 days) phase of ICU stay. For instance, an increase in lactate concentration from 2.0 mmol/L to 3.0 mmol/L during a time period of a day was associated with a 0.30 increase in the respiratory SOFA score per day. This was 0.27 early in the intensive care unit stay and 0.34 late in the intensive care unit stay. Statistics determined by mixed-model analysis of variance. cause this would interfere with an ongoing randomized controlled trial on the efficacy of early lactate-directed therapy (http://www.clinicaltrials.gov/ct/ show/NCT00270673?orderϭ1). Third, 60 patients were excluded because of unavailability of lactate within the first 24 hrs.
The ICU consisted of three different units to which patients were randomly admitted. In two of the three units, lactate measurement was automatically incorporated in routine blood gas analysis. In the other unit, lactate measurement was performed on clinical indication. Fifty-five of 60 excluded patients without available lactate levels were admitted to the unit where lactate was measured on clinical indication. However, the random admission of patients to one of the units guaranteed that exclusion because of missing lactate levels took place in unselected patients. This prevented selection bias.
CONCLUSION
The present study shows that both the duration and level of hyperlactatemia estimate the risk of organ failure. This risk was greater early in the ICU stay, which provides additional indirect support for the concept of early-goal directed therapy. Of all individual SOFA organ systems, respiratory and coagulation subscores were most strongly associated with lactate. Further research is warranted to elucidate the contribution of individual organs in the etiology of hyperlactatemia and to study whether early blood lactate level-guided resuscitation can actually prevent organ dysfunction.
